NZ311686A - Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a - Google Patents

Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a

Info

Publication number
NZ311686A
NZ311686A NZ311686A NZ31168696A NZ311686A NZ 311686 A NZ311686 A NZ 311686A NZ 311686 A NZ311686 A NZ 311686A NZ 31168696 A NZ31168696 A NZ 31168696A NZ 311686 A NZ311686 A NZ 311686A
Authority
NZ
New Zealand
Prior art keywords
sialyl
lewis
mimetics
diglycosylated
diols
Prior art date
Application number
NZ311686A
Inventor
Hartmuth Christian Kolb
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NZ311686A publication Critical patent/NZ311686A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/207—Cyclohexane rings not substituted by nitrogen atoms, e.g. kasugamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

ompounds of formula (I) in which X is the residue of a non-glycosidic aliphatic 1,2-diol; R1 is an S-configurated methyl substituted with one carboxyl residue and one other substituent; R2 is hydrogen, C1-C12alkyl or C6aryl; as mimetics of sialyl-Lewis X and sialyl-Lewis A. Also claimed is the preparation of compounds of formula (I) and their use as a pharmaceutical composition in the treatment of inflammation.
NZ311686A 1995-06-29 1996-06-26 Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a NZ311686A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH191495 1995-06-29
PCT/EP1996/002785 WO1997001569A1 (en) 1995-06-29 1996-06-26 Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a

Publications (1)

Publication Number Publication Date
NZ311686A true NZ311686A (en) 2000-01-28

Family

ID=4221546

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ311686A NZ311686A (en) 1995-06-29 1996-06-26 Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a

Country Status (19)

Country Link
EP (1) EP0836610A1 (en)
JP (1) JPH11508548A (en)
KR (1) KR19990028543A (en)
CN (1) CN1196731A (en)
AU (1) AU707474B2 (en)
BR (1) BR9609285A (en)
CA (1) CA2224346A1 (en)
CZ (1) CZ419797A3 (en)
EA (1) EA001356B1 (en)
HU (1) HUP9801805A3 (en)
IL (1) IL118740A0 (en)
MX (1) MX9800218A (en)
NO (1) NO976065L (en)
NZ (1) NZ311686A (en)
PL (1) PL324258A1 (en)
SI (1) SI9620099A (en)
SK (1) SK177897A3 (en)
TR (1) TR199701728T1 (en)
WO (1) WO1997001569A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002036587A2 (en) 2000-11-01 2002-05-10 Cor Therapeutics, Inc. Process for the production of 4-quinazolinylpiperazin-1-carboxylic acid phenylamides
EP1577289A1 (en) * 2004-03-18 2005-09-21 Revotar Biopharmaceuticals AG Non-glycosylated/-glycosidic/-peptidic small molecule selectin inhibitors for the treament of inflammatory disorders
AU2006284578B2 (en) 2005-09-02 2011-01-27 Glycomimetics, Inc. Heterobifunctional pan-selectin inhibitors
EP1764096A1 (en) 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel phloroglucinol derivatives having selectin ligand activity
EP1764095A1 (en) 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel nitrocatechol derivatives having selectin ligand activity
EP1764093A1 (en) 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel aromatic compounds and their use in medical applications
JP5298020B2 (en) * 2006-10-12 2013-09-25 グリコミメティクス， インコーポレイテッド Glucose mimic substitution of hexose and N-acetylhexosamine
JP5511390B2 (en) * 2007-02-09 2014-06-04 グリコミメティクス， インコーポレイテッド Method of using a sugar mimetic having a hexose and N-acetylhexosamine substitution
WO2009126556A1 (en) 2008-04-08 2009-10-15 Glycomimetics, Inc. Pan-selectin inhibitor with enhanced pharmacokinetic activity
WO2012037034A1 (en) 2010-09-14 2012-03-22 Glycomimetics, Inc. E-selectin antagonists
JP2015500887A (en) 2011-12-22 2015-01-08 グリコミメティクス， インコーポレイテッド E-selectin antagonist compounds, compositions and methods of use
AU2013355238B2 (en) 2012-12-07 2017-12-14 Glycomimetics, Inc. Compounds, compositions and methods using E-selectin antagonists for mobilization of hematopoietic cells
SI3227310T1 (en) 2014-12-03 2019-11-29 Glycomimetics Inc Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors
CA3009836A1 (en) 2016-01-22 2017-07-27 Glycomimetics, Inc. Glycomimetic inhibitors of pa-il and pa-iil lectins
US11291678B2 (en) 2016-03-02 2022-04-05 Glycomimetics, Inc Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin
WO2018031445A1 (en) 2016-08-08 2018-02-15 Glycomimetics, Inc. Combination of t-cell checkpoint inhibitors with inhibitors of e-selectin or cxcr4, or with heterobifunctional inhibitors of both e-selectin and cxcr4
JP7069136B2 (en) 2016-10-07 2022-05-17 グリコミメティクス， インコーポレイテッド Extremely potent multimeric E-selectin antagonist
EP3596096A1 (en) 2017-03-15 2020-01-22 GlycoMimetics, Inc. Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists
JP7275131B2 (en) 2017-11-30 2023-05-17 グリコミメティクス， インコーポレイテッド Methods of mobilizing bone marrow-infiltrating lymphocytes and uses thereof
CN111566117A (en) 2017-12-29 2020-08-21 糖模拟物有限公司 Heterobifunctional inhibitors of E-selectin and galectin-3
JP7455064B2 (en) 2018-03-05 2024-03-25 グリコミメティクス， インコーポレイテッド Methods of treating acute myeloid leukemia and related conditions
WO2020139962A1 (en) 2018-12-27 2020-07-02 Glycomimetics, Inc. Heterobifunctional inhibitors of e-selectin and galectin-3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5326752A (en) * 1991-11-27 1994-07-05 Glycomed Incorporated Substituted lactose and lactosamine derivatives as cell adhesion inhibitors
WO1993023031A1 (en) * 1992-05-08 1993-11-25 The Biomembrane Institute Multivalent mimetics and peptide mimetics for blocking carbohydrate-dependent cellular interaction and for eliciting anticarbohydrate t-cell response
CA2100412A1 (en) * 1992-07-15 1994-01-16 Yutaka Yamada Glycolipid derivatives

Also Published As

Publication number Publication date
AU6305396A (en) 1997-01-30
KR19990028543A (en) 1999-04-15
NO976065D0 (en) 1997-12-23
EA001356B1 (en) 2001-02-26
EA199800103A1 (en) 1998-08-27
BR9609285A (en) 1999-05-11
CN1196731A (en) 1998-10-21
MX9800218A (en) 1998-07-31
PL324258A1 (en) 1998-05-11
JPH11508548A (en) 1999-07-27
TR199701728T1 (en) 1998-03-21
SK177897A3 (en) 1998-08-05
NO976065L (en) 1998-02-17
IL118740A0 (en) 1996-10-16
HUP9801805A3 (en) 2002-01-28
HUP9801805A2 (en) 1998-12-28
EP0836610A1 (en) 1998-04-22
CA2224346A1 (en) 1997-01-16
WO1997001569A1 (en) 1997-01-16
AU707474B2 (en) 1999-07-08
SI9620099A (en) 1998-08-31
CZ419797A3 (en) 1998-06-17

Similar Documents

Publication Publication Date Title
NZ311686A (en) Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a
AU4950993A (en) Combination of germicidal agents
MY118354A (en) 1,3-propane diol derivatives as bioactive compounds
MX9709351A (en) HIGH THREONINE DERIVATIVES OF 'alpha'-HORDOTHIONIN.
BG102425A (en) (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors
YU47204B (en) DERIVATI DIDEHIDRO-VITAMINA D3
NO308076B1 (en) Azadioxacycloalkenes, fungicides containing these, uses for the preparation of fungicides, and intermediates
ZA948669B (en) New pyrazine carboxamide derivatives the preparation thereof and their use in pharmaceutical compositions
ATE172735T1 (en) TROPYL 7-AZAINDOL-3-YLCARBOXAMIDE AS AN ANTITUSSIVE
BR9406260A (en) Stable composition use of a composition and medium susceptible to microbiological contamination
CA2056421A1 (en) Agent against autoimmune diseases
CA2080249A1 (en) Preparation of substituted piperidines
IL97277A0 (en) Beta-phenylisoserine derivative,and its preparation and application
IL111966A0 (en) 4-Benzoylisoxazole derivatives, their preparation and herbicidal compositions containing them
ES2007419A6 (en) Antitumor anthracycline glycosides, intermediates thereof, and composition and use thereof
ES2006488A6 (en) New anthracyclines
IL113899A0 (en) Fungicidal compositions and their uses
MX9700712A (en) Streptogramine derivatives, preparation of same and pharmaceutical compositions containing same.
HU9503388D0 (en) Anxiolytic agent
AU7610194A (en) Thiocarbamoyl compounds used as antimicrobial agents
AU1067295A (en) Substituted aminoalkylaminopyridines
DE3824939A1 (en) Antimycotic compositions containing 2,2-dihalocyclopropylhydroxyethyltriazoles